Exercise for Colorectal Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how exercise (also known as physical activity, workout, or fitness training) affects the gut microbiome, chemotherapy side effects, and overall treatment outcomes for individuals undergoing chemotherapy for colorectal cancer. Participants will be divided into two groups: one will engage in regular exercise sessions, while the other will maintain their usual activity level and join the exercise program later. Individuals with early-stage or metastatic colorectal cancer, who are undergoing chemotherapy and currently exercise less than 90 minutes per week, might be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research on exercise and cancer treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with your doctor or the study team.
What prior data suggests that exercise is safe for individuals with colorectal cancer?
Research shows that exercise is generally safe for people with colorectal cancer. A review of studies found that exercise after a colorectal cancer diagnosis links to a low risk of negative side effects, indicating that most people handled the exercise well without serious issues.
One study found that colon cancer survivors who exercised regularly had a 28% lower chance of cancer recurrence. Additionally, those who followed a structured exercise program had a 37% lower risk of death. These findings suggest that exercise is not only safe but might also provide important health benefits for those with colorectal cancer.
Overall, exercise appears to be a well-tolerated and potentially beneficial activity for people with colorectal cancer.12345Why are researchers excited about this trial?
Researchers are excited about using exercise as a treatment for colorectal cancer because it offers a non-invasive, drug-free approach that can complement existing therapies like surgery, chemotherapy, and radiation. Unlike traditional treatments that often have significant side effects, exercise may enhance patients' overall well-being and potentially improve treatment outcomes by boosting physical fitness and reducing fatigue. Additionally, exercise can be easily integrated into daily life, making it an accessible option for many patients seeking to enhance their quality of life during and after cancer treatment.
What evidence suggests that exercise is effective for colorectal cancer?
Research has shown that exercise might benefit people with colorectal cancer. One study found that physical activity reduced the risk of colon cancer by 24%. Another study demonstrated that exercising after surgery and chemotherapy lowered the chance of cancer recurrence or new cancer development. Over eight years, participants who exercised had better survival rates. Exercise also improved the quality of life for colorectal cancer survivors. This trial will compare an Exercise Group, where participants will complete exercise sessions three times weekly, with a Waitlist Control Group, who will maintain their usual activities. This evidence suggests that exercise could be helpful for those with colorectal cancer.26789
Who Is on the Research Team?
Christina M Dieli-Conwright, PhD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for individuals with early-stage or metastatic colorectal cancer who are currently undergoing chemotherapy. Participants should be willing to either engage in an exercise program or be placed on a waitlist as part of the control group.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo chemotherapy and are assigned to either an exercise group or a waitlist control group. The exercise group completes exercise sessions 3 times weekly.
Follow-up
Participants are monitored for changes in microbiome activity and chemotherapy toxicity after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
American Cancer Society, Inc.
Collaborator